| Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies HT Kuo, H Merkens, Z Zhang, CF Uribe, J Lau, C Zhang, N Colpo, KS Lin, ... Molecular pharmaceutics 15 (11), 5183-5191, 2018 | 99 | 2018 |
| Accuracy of 177Lu activity quantification in SPECT imaging: a phantom study CF Uribe, PL Esquinas, J Tanguay, M Gonzalez, E Gaudin, ... EJNMMI physics 4, 1-20, 2017 | 66 | 2017 |
| Machine Learning in Nuclear Medicine: Part 1—Introduction CF Uribe, S Mathotaarachchi, V Gaudet, KC Smith, P Rosa-Neto, ... Journal of Nuclear Medicine 60 (4), 451-458, 2019 | 57 | 2019 |
| 177Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio HT Kuo, KS Lin, Z Zhang, CF Uribe, H Merkens, C Zhang, F Bénard Journal of Nuclear Medicine 62 (4), 521-527, 2021 | 54 | 2021 |
| Determination of gamma camera calibration factors for quantitation of therapeutic radioisotopes W Zhao, PL Esquinas, X Hou, CF Uribe, M Gonzalez, JM Beauregard, ... EJNMMI physics 5, 1-16, 2018 | 52 | 2018 |
| Functionally Versatile and Highly Stable Chelator for 111In and 177Lu: Proof-of-Principle Prostate-Specific Membrane Antigen Targeting L Li, MG Jaraquemada-Pelaez, HT Kuo, H Merkens, N Choudhary, ... Bioconjugate chemistry 30 (5), 1539-1553, 2019 | 48 | 2019 |
| In vivo 3T and ex vivo 7T diffusion tensor imaging of prostate cancer: Correlation with histology CF Uribe, EC Jones, SD Chang, SL Goldenberg, SA Reinsberg, ... Magnetic resonance imaging 33 (5), 577-583, 2015 | 42 | 2015 |
| Feasibility of single-time-point dosimetry for radiopharmaceutical therapies X Hou, J Brosch, C Uribe, A Desy, G Böning, JM Beauregard, A Celler, ... Journal of Nuclear Medicine 62 (7), 1006-1011, 2021 | 37 | 2021 |
| Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs C Miller, J Rousseau, CF Ramogida, A Celler, A Rahmim, CF Uribe Theranostics 12 (1), 232, 2022 | 35 | 2022 |
| Positron emission tomography imaging of the gastrin-releasing peptide receptor with a novel bombesin analogue J Lau, E Rousseau, Z Zhang, CF Uribe, HT Kuo, J Zeisler, C Zhang, ... ACS omega 4 (1), 1470-1478, 2019 | 33 | 2019 |
| JADA: a graphical user interface for comprehensive internal dose assessment in nuclear medicine J Grimes, C Uribe, A Celler Medical physics 40 (7), 072501, 2013 | 30 | 2013 |
| Effects of adding an albumin binder chain on [177Lu] Lu-DOTATATE E Rousseau, J Lau, Z Zhang, CF Uribe, HT Kuo, C Zhang, J Zeisler, ... Nuclear medicine and biology 66, 10-17, 2018 | 28 | 2018 |
| Comprehensive SPECT/CT system characterization and calibration for 177Lu quantitative SPECT (QSPECT) with dead-time correction A Frezza, C Desport, C Uribe, W Zhao, A Celler, P Després, ... EJNMMI physics 7, 1-22, 2020 | 27 | 2020 |
| Characteristics of Bremsstrahlung emissions of 177 Lu, 188 Re, and 90 Y for SPECT/CT quantification in radionuclide therapy CF Uribe, PL Esquinas, M Gonzalez, A Celler Physica Medica 32 (5), 691-700, 2016 | 27 | 2016 |
| An international study of factors affecting variability of dosimetry calculations, part 1: design and early results of the SNMMI dosimetry challenge C Uribe, A Peterson, B Van, R Fedrigo, J Carlson, J Sunderland, E Frey, ... Journal of Nuclear Medicine 62 (Supplement 3), 36S-47S, 2021 | 23 | 2021 |
| Machine Learning in Nuclear Medicine: Part 2—Neural Networks and Clinical Aspects K Zukotynski, V Gaudet, CF Uribe, S Mathotaarachchi, KC Smith, ... Journal of Nuclear Medicine 62 (1), 22-29, 2021 | 22 | 2021 |
| Deadtime effects in quantification of 177Lu activity for radionuclide therapy CF Uribe, PL Esquinas, M Gonzalez, W Zhao, J Tanguay, A Celler EJNMMI physics 5, 1-16, 2018 | 22 | 2018 |
| Evaluation of dead-time corrections for post-radionuclide-therapy 177Lu quantitative imaging with low-energy high-resolution collimators A Celler, H Piwowarska-Bilska, S Shcherbinin, C Uribe, R Mikolajczak, ... Nuclear medicine communications 35 (1), 73-87, 2014 | 22 | 2014 |
| Evaluation of dead-time corrections for post-radionuclide-therapy 177Lu quantitative imaging with low-energy high-resolution collimators A Celler, H Piwowarska-Bilska, S Shcherbinin, C Uribe, R Mikolajczak, ... Nuclear medicine communications 35 (1), 73-87, 2014 | 22 | 2014 |
| Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T J Brosch-Lenz, C Uribe, A Gosewisch, L Kaiser, A Todica, H Ilhan, ... EJNMMI physics 8, 1-17, 2021 | 20 | 2021 |
Arman RahmimProfessor of Radiology, Physics and Biomedical Engineering, University of British ColumbiaBestätigte E-Mail-Adresse bei ubc.ca
